Rezor-40 Tablet

About Rezor-40 Tablet

Rezor-40 is a 40 mg tablet from Renata PLC. that contains Olmesartan Medoxomil, a medicine used to treat high blood pressure. It belongs to the angiotensin-II receptor blocker class and is taken as your doctor advises.

There are 29 brands of Olmesartan Medoxomil listed in Bangladesh. The lowest listed price is Belsar 10 mg Tablet at ৳ 6.00 per unit.

What is Rezor-40 Tablet?

Rezor-40 is a 40 mg tablet made by Renata PLC. Its active ingredient is Olmesartan Medoxomil, which belongs to a group of medicines called angiotensin-II receptor blockers. It is used for high blood pressure and can be prescribed on its own or together with other blood pressure medicines. It works by blocking the action of angiotensin-II, a substance in the body that narrows blood vessels, so blood vessels can relax. The dose and course are set by your doctor, so follow the instructions you are given.

Uses of Rezor-40

Rezor-40 is used to treat high blood pressure (hypertension). Your doctor may prescribe it alone or alongside other medicines that lower blood pressure. Because high blood pressure often has no obvious signs, keep taking it as prescribed and attend your follow-up checks. Do not change or stop the medicine on your own; ask your doctor if you have questions about your treatment.

How to use Rezor-40

Take Rezor-40 exactly as your doctor tells you. The doctor decides the dose and how long you take it, so follow that advice rather than any general routine. Swallow the tablet as directed. Food does not change how the body absorbs Olmesartan, so you can take it with or without food unless your doctor says otherwise. If you miss a dose, ask your doctor or pharmacist what to do.

Side effects of Rezor-40

Some people may notice side effects while taking Rezor-40. Commonly reported ones include back pain, bronchitis, diarrhea, headache, flu-like symptoms, sore throat, runny nose, sinusitis, and changes in certain blood test results. Less common effects include chest pain, swelling of the ankles or feet, and joint pain. Tell your doctor or pharmacist if you feel unwell or notice anything unusual, and seek medical help for severe symptoms.

Safety and precautions

Tell your doctor before starting Rezor-40 if you are allergic to any of its ingredients, as it should not be used in that case. It is not to be used during pregnancy; if pregnancy is suspected or confirmed, contact your doctor straight away. If you are breastfeeding, ask your doctor before use, because it is not known whether the medicine passes into breast milk. People with kidney problems or heart failure should be checked by a doctor first. Ask your doctor or pharmacist about any concerns.

Frequently asked questions

How should Rezor-40 be stored?

Keep the tablets in a cool, dry place below 30°C, away from light and moisture. Store them out of the reach of children. Do not use tablets after the expiry date, and ask your pharmacist if you are unsure how to dispose of unused medicine.

What is Rezor-40 used for and what kind of medicine is it?

Rezor-40 is a 40 mg tablet containing Olmesartan Medoxomil, an angiotensin-II receptor blocker. It is used to treat high blood pressure and may be taken alone or with other blood pressure medicines. Your doctor decides the dose and course.

Which medicines may interact with Rezor-40?

No significant drug interactions were reported when Olmesartan was taken with other medicines. Even so, tell your doctor or pharmacist about every medicine you use, including ones bought without a prescription, so they can check whether anything needs to be adjusted.

What should I do if I miss a dose or take too much?

Ask your doctor or pharmacist what to do about a missed dose; do not double up unless they tell you to. If you think you have taken too much, contact a doctor or hospital promptly, because low blood pressure and a fast heartbeat are possible.

Indications

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Pharmacology

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

Dosage & Administration

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

Interaction

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

Contraindications

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

Side Effects

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

Pregnancy & Lactation

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

Overdose Effects

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

Storage Conditions

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

Alternative brands of Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 29 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.